4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0000950170-25-008451
President and CEO sold 375,000 shares at an average $4.70 ($1,762,500)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Sanjiv President and CEO | 2025-01-21 | Sale 10b5-1 | −125,000 | $4.52 | $565,000 | 449,548 | I |
| Patel Sanjiv President and CEO | 2025-01-22 | Sale 10b5-1 | −125,000 | $4.80 | $600,000 | 324,548 | I |
| Patel Sanjiv President and CEO | 2025-01-23 | Sale 10b5-1 | −125,000 | $4.78 | $597,500 | 199,548 | I |
| Open-market sales · 375,000 sh · avg $4.70 · $1,762,500 | |||||||
Loading xslF345X05/ownership.xml…